Nymox Pharmaceutical Corporation - stock earnings
Stock symbol NYMX is outdated, potentially delisted? Maybe it is available on other exchange?
NYMX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022Q4 | -1.3 million USD | ? USD |
| 2022Q3 | -1.5 million USD | ? USD |
| 2022Q2 | 1.3 million USD | ? USD |
| 2022Q1 | -5.1 million USD | ? USD |
| 2021Q4 | -2.8 million USD | ? USD |
| 2021Q3 | -3.3 million USD | ? USD |
| 2021Q2 | -4.0 million USD | ? USD |
| 2021Q1 | -2.4 million USD | ? USD |
| 2020Q4 | -2.0 million USD | ? USD |
| 2020Q3 | -4.2 million USD | ? USD |
NYMX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2022 | -6.6 million USD | ? USD |
| 2021 | -12.5 million USD | ? USD |
| 2020 | -11.7 million USD | 5000 USD |
| 2019 | -13.2 million USD | 116000 USD |
| 2018 | -10.6 million USD | 299000 USD |
| 2017 | -13.4 million USD | 224000 USD |
NYMX
Price: $0.20
52 week price:
Earnings Per Share: -0.15 USD
P/E Ratio: -10.83
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 140300
Ebitda: -11.2 millionMarket Capitalization: 43.0 million